New study finds bone density screenings for women over 65 years have dropped, especially for Black women; lack of post-fracture care puts patients at risk
A new perspective article published in the Lancet Diabetes & Endocrinology has highlighted that screening and treatment of osteoporosis lags behind other diseases, resulting in significant morbidity, mortality, and economic costs.